Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tenda Co., Ltd. (4198:JPX), powered by AI.
Tenda Co., Ltd. is currently trading at ¥509. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Tenda Co., Ltd. on Alpha Lenz.
Tenda Co., Ltd.'s P/E ratio is 13.1.
“Tenda Co., Ltd. trades at a P/E of 13.1 (undervalued) with solid ROE of 9.7%. 3Y revenue CAGR of 16.7% highlights clear growth momentum.”
Ask for details →Tenda Co., Ltd. is a company that specializes in the healthcare industry, with a focus on the development and provision of medical services and pharmaceuticals. The company is primarily engaged in the operation of pharmacies and the wholesale distribution of pharmaceutical products, playing a crucial role in ensuring the availability and accessibility of medications to a broad customer base. Tenda Co., Ltd. contributes significantly to the healthcare sector by facilitating the efficient supply of essential drugs and medical supplies. With its network of pharmacies, the company serves a diverse clientele, including healthcare institutions, clinics, and individual consumers, providing them with a variety of health-related products and services. Tenda Co., Ltd.'s activities are vital to the medical supply chain, supporting public health initiatives and contributing to the wellbeing of communities. Its operations in the pharmaceutical wholesale sector underscore its importance in maintaining a steady flow of medical supplies in the market, illustrating its role as a pivotal entity in the healthcare ecosystem.
“Tenda Co., Ltd. trades at a P/E of 13.1 (undervalued) with solid ROE of 9.7%. 3Y revenue CAGR of 16.7% highlights clear growth momentum.”
Ask for details →Tenda Co., Ltd. (ticker: 4198) is a company listed on JPX in the Technology sector (Information Technology Services). It has approximately 370 employees. Market cap is $3.4B.
The current price is 509 with a P/E ratio of 13.05x and P/B of 1.23x.
ROE is 9.70% and operating margin is 7.68%. Annual revenue is $5.6B.